What am I missing?Hello fellow Bullboardians, I am starting to look at medical stocks in addition to what I traditionally trade and need some general advice from the group. I'm looking at MDNA financials and can't find a way to justify/prove how there can be a $2-$3 share price on 23M shares outstanding. Does everyone accept that companies like this bleed cash and buy-in hoping to hit the rocket blast up if the research pays off? What's the model here? Thanks all.